APT Pharma

APT Pharma Limited is a prominent pharmaceutical manufacturer and distributor based in Hong Kong, operating as a wholly-owned subsidiary of Jacobson Pharma Corporation Limited. The company specializes in the production and marketing of generic drugs, with a particular focus on specialized formulations for chronic diseases and essential medicines. APT Pharma is a key supplier to the Hong Kong Hospital Authority, providing a wide range of products across therapeutic areas such as cardiovascular, respiratory, and central nervous system health. Originally acquired from Merck KGaA in 2005, the company has established itself as a cornerstone of the regional pharmaceutical market, leveraging its GMP-certified facilities to deliver high-quality, cost-effective healthcare solutions.